期刊文献+

47例肝门部胆管癌的相关预后影响因素分析 被引量:4

Analysis of the prognosis factors of hilar cholangiocarcinoma
下载PDF
导出
摘要 目的探讨影响肝门部胆管癌的预后因素。方法回顾性分析2006年1月至2009年1月47例肝门部胆管癌患者的临床资料,分析肝门部胆管癌的预后影响因素。结果全组患者的1年生存率为63.6%,3年生存率为18.2%,5年生存率为6.8%。Cox回归模型分析显示肿瘤分期和局部浸润与转移是影响肝门部胆管癌患者预后的独立风险因素。结论肝门部胆管癌的预后与肿瘤分期和局部浸润与转移密切相关,选择适宜的治疗方式,有望获得良好的近远期治疗效果。 Objective To investigate the prognosis factors of hilar cholangiocarcinoma(HCC). Methods The clinical data were retrospectively analyzed in 47 cases of hilar cholangioearcinoma admitted into our hospital from Jan. 2006 to Jan. 2009. Results Of 47 cases with hilar cholangiocarcinoma, 1-year survival, 3-year survival and 5-year survival were 63.6% , 18.2% and 6.8%. Cox regression analysis showed that TNM stage and distant metastases were the dependent prognosis factors, while the age, gender, Bisnmth-Corlette type, TBIL before operation, CA19-9 level were not the dependent prognosis factors. Conclusions The prognosis of hilar cholangiocarcinoma correlates with clinical stage and distant metastases. Choosing an appropriate treatment can achieve a better short-term and long-term outcomes.
出处 《中国肿瘤外科杂志》 CAS 2014年第4期211-214,共4页 Chinese Journal of Surgical Oncology
关键词 肝门部胆管癌 外科治疗 预后因素 hilar cholangiocarcinoma surgical procedure prognosis factors
  • 相关文献

参考文献3

二级参考文献49

共引文献138

同被引文献50

  • 1刘晶,丁洋,胡键阳,李明皓.51例肝门部胆管癌外科治疗及预后分析[J].宁夏医科大学学报,2013,35(3):333-336. 被引量:1
  • 2Fukude S, Mukai S, Shimizu S, et al. Heterotopic gastric mu-cosa in the hilar bile duct mimicking hilar cholangiocarcinoma :Report of a case [J]. Surgery Today, 2013,43(1) :91-95.
  • 3王娟,公维宏,张宏涛.放射性M粒子植人治疗消化道恶性肿瘤的临床分析[C].天津:中国抗癌协会,2013.
  • 4Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma [ J ]. Hepatobiliary Pancreat Dis Int,2012, 11 ( 1 ) : 12-17.
  • 5Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma[ J ]. Semin Intervent Radiol, 2008,25 ( 2 ) : 110-122.
  • 6Nagino M. Perihilar cholangiocarcinoma : a surgeon' s viewpoint on current topics [ J ]. J Gastroenterol, 2012,47 ( 11 ) : 1165-1176.
  • 7Darwish Murad S, Kim WR, Themeau T, et al. Predictors of pre- transplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma [ J ]. Hepatology, 2012, 56 ( 3 ) : 972-981.
  • 8Salgia RJ, Singal AG, Fu S, et al. Improved Post-Transplant Sur- vival in the United States for Patients with CholangiocarcinomaAfter 2000 [ J ]. Dig Dis Sci, 2014,59 (5) : 1048-1054.
  • 9Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoad- juvant chemoradiation, followed by liver transplantation, for pefi- hilar cholangiocarcinoma at 12 US centers [ J ]. Gastroenterology, 2012,143( 1 ) :88-98.
  • 10黄志强.肝门部胆管癌外科治疗25年的历程[J].中华消化外科杂志,2010,9(3):161-164. 被引量:22

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部